Skip to main content

Day: March 25, 2026

Nkarta Reports Fourth Quarter and Full Year 2025 Financial Results and Corporate Highlights

Dose escalation for NKX019 advanced to 4 billion cells per dose on days 0, 3 and 7 for a total of 12 billion cells per cycle Initial clinical data from Ntrust-1 and Ntrust-2 targeted for presentation at a medical conference in 2026 Cash balance of $295.1 million on December 31, 2025, including cash, cash equivalents and investments, is expected to fund operations into 2029SOUTH SAN FRANCISCO, Calif., March 25, 2026 (GLOBE NEWSWIRE) — Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biotechnology company developing engineered natural killer (NK) cell therapies to treat autoimmune diseases, today reported financial results for the fourth quarter and year ended December 31, 2025.  “2025 was a year of strategic importance for Nkarta as we onboarded a clinical team with deep autoimmune experience, right-sized our workforce to be a responsible...

Continue reading

Journey Medical Corporation Reports Full-Year 2025 Financial Results and Recent Corporate Highlights

Total revenues were $61.9 million in FY2025 compared to $56.1 million in FY2024 Emrosi™ generated net revenues of $14.7 million during the full-year period after its launch in early April 2025 Approximately 53,000 total prescriptions were filled for Emrosi™ during FY2025 Payer access for Emrosi™ available to over 100 million U.S. commercial lives Company to hold conference call today at 4:30 p.m. ET SCOTTSDALE, Ariz., March 25, 2026 (GLOBE NEWSWIRE) — Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical,” “the Company,” “we” or “our”), a commercial-stage pharmaceutical company focused on developing, selling and marketing FDA-approved prescription pharmaceutical products for the treatment of dermatological conditions, today announced financial results and recent corporate highlights for the full year...

Continue reading

Celcuity Inc. Reports Release of Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

The U.S. Food and Drug Administration (“FDA”) accepted Celcuity’s New Drug Application (“NDA”) and granted Priority Review with a Prescription Drug User Fee Act (“PDUFA”) goal date of July 17, 2026, for gedatolisib in HR+/HER2-/PIK3CA wild-type (“WT”) advanced breast cancer (“ABC”) Results from PIK3CA WT cohort of Phase 3 VIKTORIA-1 study of gedatolisib regimens in HR+/HER2- ABC published in Journal of Clinical Oncology Topline results from the PIK3CA mutant cohort of the Phase 3 VIKTORIA-1 study are expected to be released in the second quarter of 2026 Management to host webcast and conference call today, March 25, 2026, at 4:30 p.m. EDTMINNEAPOLIS, March 25, 2026 (GLOBE NEWSWIRE) — Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced financial...

Continue reading

E-Power Inc. Announces Strategic Expansion into Vietnam to Build a Resilient “Ex-China” Anode Material Supply Chain for Global AI Data Centers and ESS Markets

DOVER, USA, March 25, 2026 (GLOBE NEWSWIRE) — E-Power Inc. (“E-Power”, the “Company”, “we” or “our”) (NASDAQ: EPOW), a global leader in energy storage battery anode materials and integrated microgrid solutions, today announced a significant milestone in its global expansion strategy following a successful high-level site inspection of the ATSC SOLARTECH facility in Hung Yen Province, Vietnam. This initiative aligns with the Company’s “Closed-Loop” industrial ecosystem, focusing on localized production to serve the rapidly growing Artificial Intelligence Data Center (AIDC) and energy storage markets in North America and Southeast Asia. Strategic Collaboration and Global Supply Chain Resilience The Company’s leadership team recently concluded a strategic visit to the ATSC SOLARTECH factory, engaging in in-depth discussions...

Continue reading

Seattle Mariners Upgrade Video Board at T-Mobile Park with Daktronics

T-Mobile Park updates cover 11,300+ square feet of digital canvas in the outfield for video, replays and moreBROOKINGS, S.D., March 25, 2026 (GLOBE NEWSWIRE) — Continuing to evolve the digital display experience at T-Mobile Park, the Seattle Mariners have turned to Daktronics (NASDAQ: DAKT) of Brookings, South Dakota, to manufacture and install an upgraded outfield video display, now named Mariners Fire TV, totaling more than 11,300 square feet. The size remains squarely in the top 10 in baseball’s major league and is installed and ready for the first pitch of the 2026 season in Seattle, Washington. “We pride ourselves in consistently finding ways to elevate the fan experience at T-Mobile Park, and the new Mariners Fire TV in center field represents another great opportunity to make a meaningful impact,” said Mariners Vice President...

Continue reading

Eldorado Gold Announces Leading, Independent Proxy Advisory Firm, ISS, Recommends Eldorado Shareholders Vote “FOR” the Proposed Arrangement with Foran Mining; Shareholders Reminded to Vote

Your vote is important. Vote well in advance of the proxy voting deadline on Thursday, April 2, 2026 at 10:00 a.m. (Vancouver time). Shareholder questions or need voting assistance? Please contact Laurel Hill Advisory Group by email at assistance@laurelhill.com, or by texting INFO to, or calling, 1-877-452-7184 (North American toll-free) or 1-416-304-0211 (outside North America).VANCOUVER, British Columbia, March 25, 2026 (GLOBE NEWSWIRE) — Eldorado Gold Corporation (TSX: ELD, NYSE American: EGO) (“Eldorado” or the “Company”) is pleased to announce that Institutional Shareholder Services (“ISS”), a leading proxy advisory firm, has recommended that shareholders vote FOR the ordinary resolution (the “Eldorado Share Issuance Resolution”) to approve the issuance of Eldorado shares in connection with the proposed plan...

Continue reading

Casino Group: Release of 2025 financial data estimates on 30 March 2026

Release of 2025 financial data estimates on 30 March 2026  Paris, 25 March 2026 Further to its press release dated 18 February 20261, the Group announces that it will release 2025 financial data estimates on 30 March 2026 (after market closing). A conference call will be held on the same day. *** ANALYSTS AND INVESTORS CONTACTS Charlotte IZABEL – cizabel@groupe-casino.fr – Tel: +33 (0)6 89 19 88 33 IR_Casino@groupe-casino.fr – Tel: +33 (0)1 53 65 24 17 PRESS CONTACTS Casino Group – Communications Department Stéphanie ABADIE – sabadie@groupe-casino.fr – Tel: +33 (0)6 26 27 37 05 directiondelacommunication@groupe-casino.fr – Tel: + 33(0)1 53 65 24 291 Press release dated 18 February 2026Attachment2026-03-25 – PR – Casino Group Communication

Continue reading

Tevogen Regains Compliance with Nasdaq Minimum Bid Price Requirement

Tevogen Regains Compliance with Nasdaq Minimum Bid Price RequirementTevogen Regains Compliance with Nasdaq Minimum Bid Price RequirementWARREN, N.J., March 25, 2026 (GLOBE NEWSWIRE) — Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN) received written notice (the “Notification Letter”) from The Nasdaq Stock Market LLC notifying the Company that it had regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5450(a)(1) for continued listing on The Nasdaq Global Market. As previously disclosed on September 23, 2025, the Company received a notification letter from the Staff of Nasdaq indicating that the Company was not in compliance with the minimum bid price requirement of $1.00 per share for continued listing under Nasdaq Listing Rule 5450(a)(1) (the “Bid Price Requirement”),...

Continue reading

JCDecaux wins Rostock’s exclusive street furniture advertising contract

JCDecaux wins Rostock’s exclusive street furniture advertising contract Paris, March 25th, 2026 – JCDecaux SE (Euronext Paris: DEC), the number one outdoor advertising company worldwide, announces that Wall GmbH, a subsidiary of JCDecaux, has been awarded following a tender process the exclusive contract for analogue and digital advertising street furniture in the city of Rostock. Wall will renovate the existing Bus shelters and digitise the key locations in the city. As the largest city in the state of Mecklenburg-Western Pomerania, with 175,000 inhabitants, and a major Baltic Sea port, Rostock is a key economic and scientific hub in northern Germany. It is also home to the iconic seaside resort of Warnemünde, one of Germany’s most renowned tourist destinations. Jean-François Decaux, Chairman of the Executive Board and Co-CEO of JCDecaux,...

Continue reading

Danone successfully issues a triple-tranche bond totaling €1.6 billion equivalent

Press release – Paris, March 25, 2026, at 6:45 PM CET Danone successfully issues a triple-tranche bond totaling €1.6 billion equivalent         Danone announces that it has today launched a triple-tranche bond offering with a total equivalent amount of €1.6 billion, comprising:a €700 million tranche of 4-year notes, carrying a 3.3790 % coupon;a €500 million tranche of 8-year notes, carrying a 3.7850 % coupon;a £350 million tranche of 6.5-year notes, carrying a 5.3250 % coupon.In line with the company’s active liquidity management, this issue enables Danone to enhance its funding flexibility while extending the maturity of its debt. The settlement is expected to take place on April 1st, 2026, and the bonds will be listed on Euronext Paris. The bond issue was widely subscribed by a diversified investor base, confirming the high...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.